| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 08.12. | Vertex Pharmaceuticals Incorporated: Vertex Presents Positive Long-Term Data On CASGEVY (exagamglogene autotemcel) at the American Society of Hematology (ASH) Annual Meeting and Exposition and Provides Program Update | 451 | Business Wire | - Data from long-term follow-up of patients in clinical trials further demonstrate durability of the transformative benefits of CASGEVY -
Safety profile consistent with busulfan conditioning and... ► Artikel lesen | |
| 08.12. | Genmab A/S: Investigational Epcoritamab (DuoBody CD3xCD20) Monotherapy Achieves High Overall and Complete Response Rates in Clinical Trial of Patients With Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) in Preliminary Analysis | 447 | Business Wire | Genmab A/S (Nasdaq: GMAB):
Preliminary analyses from the EPCORECLL-1 trial demonstrates overall response rate (ORR) of 61 percent and complete response (CR) rate of 39 percent in heavily pretreated... ► Artikel lesen | |
| 08.12. | Genmab A/S: Investigational Epcoritamab (DuoBody CD3xCD20) Combination Therapy Demonstrates High Response Rates in Clinical Trial of Patients With Relapsed or Refractory (R/R) Follicular Lymphoma (FL) | 696 | Business Wire | Genmab A/S (Nasdaq: GMAB):
Results show 96 percent overall response rate (ORR), 87 percent complete response (CR), and 80 percent 21-month progression-free survival (PFS) in patients with... ► Artikel lesen |
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| NOVO NORDISK | 383 |
| TESLA | 254 |
| NVIDIA | 249 |
| BAYER | 229 |
| TUI | 197 |
| EVOTEC | 169 |
| VOLKSWAGEN | 169 |
| PALANTIR TECHNOLOGIES | 158 |
| BYD | 152 |
| NEL | 123 |
| MICROSTRATEGY | 119 |
| SUPER MICRO COMPUTER | 105 |
| RWE | 99 |
| RHEINMETALL | 91 |
| PLUG POWER | 83 |
| COMMERZBANK | 81 |
| ATOS | 80 |
| RENK GROUP | 75 |
| BASF | 74 |
| INTEL | 74 |
| TEAMVIEWER | 73 |
| ALLIANZ | 72 |
| APPLE | 69 |
| D-WAVE QUANTUM | 68 |
| NIO INC ADR | 66 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
